Details
Category: Volume 08 Issue 03 March 2020
Hits: 1032

Title: A study on the clinicopathological correlation of psoriasis with extent of expression of Osteopontin in OPD patients

Authors: Dr Medha Yadav, Dr Vivek Gupta, Dr Sangita Bohara, Dr Sunil Kumar Gupta

 DOI: https://dx.doi.org/10.18535/jmscr/v8i3.123

Abstract

   

Objective: To evaluate the clinico-pathological Correlation of Osteopontin in patients of Psoriasis.

Methods: A cross-sectional clinical correlation study was done on 53 clinically diagnosed cases of psoriasis. All clinically diagnosed cases of Psoriasis were included after taking proper consent in a signed proforma. Patients were clinically evaluated and a proper history was taken including patient’s age, sex, site, duration, family history, community, Itching, nail involvement, H/O associated endocrine disorder, H/O associated skin disorders. The Psoriasis Area and Severity Index (PASI) score was evaluated on the basis of area coverage and plaque  appearance.A detailed study of histopathological features and IHC osteopontin expression was analyzed.

Results: About one fourth of patients were 20-30 &>40 years of age (26.4%). More than half of patients were males (69.8%). Lower limb was the most common affected site (75.5%). The duration of disease was 12-24 months in 50.9% patients. Psoriasis vulgaris was the most common clinical diagnosis (26.4%). Induration was among majority of patients (94.3%). PASI score ≥10 was among more than half of patients (60.4%). Parakeratosis and Dermal inflammation were the most common histopathological changes (96.2%). Moderate positivity of Osteopontinin the epidermis which was present among more than half of patients (60.4%) followed by weak (30.2%) and strong positivity (9.4%).In Dermis osteopontin positivity was moderate in (50.9%),followed by weak(39.6%) and strong positivity(9.4%)respectively.

Conclusion: Because of varied clinical, histopathological and IHC feature of psoriasis. A definitive diagnosis in doubtful cases can be made by a combination of all the above parameters.

Keywords: Psoriasis, Osteopontin, Histopathological changes.

References

  1. Christophers E. Psoriasis- Epidemiology and Clinical Spectrum. Clinical and Experimental Dermatology.2001; 26:314-20.
  2. Shrivastav S, Sindhu R, Kumar S, Kumar P. Anti-Psoriatic and Phytochemical Evaluation of Thespesia Populnea Bark Extracts. International Journal of Pharmacy and Pharmaceutical Science 2009; 1:176-85.
  3. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. Journal of Investigative Dermatology. 2013; 133:377-85
  4. Nickoloff BJ. Skin Innate Immune System in Psoriasis: Friend or Foe. Journal of Clinical Investigation.1999; 104:1161.
  5. Buback F, Renkl AC, Schulz G, Weiss JM. Osteopontin and the skin: Multiple emerging roles in cutaneous biology and pathology. ExpDermatol. 2009;18:750–9.
  6. Nissinen L, Kähäri VM. Matrix metalloproteinases in inflammation. J Biochim Biophys Acta. 2014;1840:2571–80.
  7. Farber EM, Nall L. Epidemiology: Natural history and genetics. In: Roenigk HH, Maibach HL, editors. Psoriasis. 3rd ed. New York: Marcel Dekker Inc.; 1998. p. 107-57.
  8. Nevitt GJ, Hutchinson PE. Psoriasis in the community: Prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 1996;135:533-7
  9. Bedi T. Clinical Profile of Psoriasis in North India.Indian Journal of Dermatology, Venereology, and Leprology. 1995;61:202
  10. Kaur I, Kumar B, Sharma VK, Kaur S. Epidemiology of psoriasis in a clinic from North India. Indian J Dermatol Venereol Leprol 1986;52:208-12.
  11. Affandi AM, Khan I, and Saaya Nooraishah Ngah. Epidemiology and Clinical Features of Adult Patients with Psoriasis in Malaysia: 10-Year Review from the Malaysian Psoriasis Registry (2007–2016). Dermatology Research and Practice 2018.
  12. Song HJ, Park CJ, Kim TY, et al. The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE). Ann Dermatol. 2017;29(4): 462–470.
  13. Chintagunta SR, Damarla SV, Gopidi PJ, Arakkal G. Pustular psoriasis – Clinical study in a tertiary care center. J NTR Univ Health Sci 2018;7:259-64.
  14. Affandi AM, Khan I, and Saaya Nooraishah Ngah. Epidemiology and Clinical Features of Adult Patients with Psoriasis in Malaysia: 10-Year Review from the Malaysian Psoriasis Registry (2007–2016). Dermatology Research and Practice 2018.
  15. Raghuveer C, Shivanand DR, Rajashekar N. Clinico-histopathological Study of Psoriasis. Int J Sci Stud 2015;3(7):176-179.
  16. Mikrani JA, Shrestha A. Clinical and Epidemiological features of Psoriasis in patients visiting Lumbini Medical College. Journal of Lumbini Medical College. 2014;2 (1):1-3.
  17. Vijayan M, Shini V.K., James E, Dharmaratnam A D. Prevalence, clinical profile and prescribing pattern of psoriasis in a tertiary care referral hospital. IJPT 2010; 2 (4): 1241-1252.
  18. Lal S, Sandana SR, Chitkara NL. Histopathology of psoriasis at various stages. Indian J Dermatol Venereol Leprol 1965; 31:216-22.
  19. Cox AJ, Watson W. Histological variations in lesions of psoriasis. Arch Dermatol 1972;106:503-6.
  20. Abdel-Mawla MY, El-Kasheshy KA, Ghonemy S, Al Balat W, Elsayed AA. Role of Osteopontin in Psoriasis: An Immunohistochemical Study. Indian J Dermatol. 2016;61(3):301–307.
  21. Amin MM, Azim ZA. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt. Indian J Pathol Microbiol 2012;55:56-60.
  22. Abdou AG , El Farargy S , Seleit I , Antar AG, Elhefny M , Elnaidany NF . Osteopontin expression in chronic plaque psoriasis: an association with the severity of disease. Analytical and Quantitative Cytology and Histology2012; 34(2):79-85.

Corresponding Author

Dr Sunil Kumar Gupta

M.D., Ex- Professor & Head, Department of Skin & V.D (U.P.), Hind Institute of Medical Sciences, Safedabad, Barabanki (U.P.), India